Common GLP-1 Inhibitors Some of the most commonly prescribed GLP-1 inhibitors include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro) Exenatide (Byetta, Bydureon) These medications are most commonly administered in the form of weekly injections, but there are a few oral formulations available on the market as well
Furthermore, periconception safety and complications rely on registries and retrospective cohorts, where confounding factors cannot be ignored (48, 132)
K.TangT.SkalameraD.GunterJ.et al (2016)
The changes in HDL-C, triglycerides, and total cholesterol were similar in STEP-1 and SELECT, and there remained a significant decrease in LDL-C even though patients started at a lower LDL-C level [33, 48]
First came Ozempic